Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker STLN
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Jorey Chernett 10% owner | STLN Starling Oncology, Inc. | Buy | 48,294 | $3.65 | $176.3K Buy | Form 4 ↗ |
| Nov 6, 2026 | Jorey Chernett 10% owner | STLN Starling Oncology, Inc. | Sale | 2.85M | $3.99 | $11.4M Sale | Form 4 ↗ |
| Aug 21, 2026 | Brad Hively Director | STLN Starling Oncology, Inc. | Sale | 298,853 | $6.51 | $1.9M Sale | Form 4 ↗ |
| Aug 14, 2026 | Jorey Chernett 10% owner | STLN Starling Oncology, Inc. | Buy | 12,000 | $6.54 | $78.5K Buy | Form 4 ↗ |
| Jul 21, 2026 | Jorey Chernett 10% owner | TOI Starling Oncology, Inc. | Buy | 18,000 | $5.27 | $94.9K Buy | Form 4 ↗ |
| Jul 14, 2026 | Yale Podnos Chief Medical Officer | TOI Starling Oncology, Inc. | Sale | 5,478 | $6.35 | $34.8K Sale | Form 4 ↗ |
| Jul 14, 2026 | Yale Podnos Chief Medical Officer | TOI Starling Oncology, Inc. | Sale | 17,974 | $6.43 | $115.6K Sale | Form 4 ↗ |
| Jul 10, 2026 | Jorey Chernett 10% owner | TOI Starling Oncology, Inc. | Buy | 15,000 | $5.85 | $87.8K Buy | Form 4 ↗ |
| Jun 23, 2026 | Jorey Chernett 10% owner | TOI Starling Oncology, Inc. | Buy | 18,000 | $5.02 | $90.4K Buy | Form 4 ↗ |
| Jun 8, 2026 | Yale Podnos Chief Medical Officer | TOI Starling Oncology, Inc. | Sale | 23,451 | $5.38 | $126.2K Sale | Form 4 ↗ |
| Jun 4, 2026 | Jorey Chernett 10% owner | TOI Starling Oncology, Inc. | Buy | 12,000 | $4.75 | $57.0K Buy | Form 4 ↗ |
| May 20, 2026 | Jorey Chernett 10% owner | TOI Starling Oncology, Inc. | Buy | 33,500 | $4.07 | $136.3K Buy | Form 4 ↗ |
| May 19, 2026 | Jorey Chernett 10% owner | TOI Starling Oncology, Inc. | Buy | 5,000 | $4.05 | $20.3K Buy | Form 4 ↗ |
| May 19, 2026 | Jorey Chernett 10% owner | TOI Starling Oncology, Inc. | Buy | 30,000 | $4.09 | $122.7K Buy | Form 4 ↗ |
| Apr 16, 2026 | Mohit Kaushal Director | TOI Starling Oncology, Inc. | Sale | 38,433 | $3.50 | $134.5K Sale | Form 4 ↗ |
| Apr 14, 2026 | Mohit Kaushal Director | TOI Starling Oncology, Inc. | Sale | 57,286 | $3.50 | $200.5K Sale | Form 4 ↗ |
| Apr 9, 2026 | Jorey Chernett 10% owner | TOI Starling Oncology, Inc. | Buy | 20,000 | $3.10 | $62.0K Buy | Form 4 ↗ |
| Mar 27, 2026 | Jorey Chernett 10% owner | TOI Starling Oncology, Inc. | Buy | 27,429 | $2.96 | $81.2K Buy | Form 4 ↗ |
| Mar 26, 2026 | Jorey Chernett 10% owner | TOI Starling Oncology, Inc. | Buy | 50,000 | $3.15 | $157.5K Buy | Form 4 ↗ |
| Mar 24, 2026 | Jorey Chernett 10% owner | TOI Starling Oncology, Inc. | Buy | 125,000 | $3.11 | $388.8K Buy | Form 4 ↗ |
| Mar 20, 2026 | Jorey Chernett 10% owner | TOI Starling Oncology, Inc. | Buy | 25,000 | $3.35 | $83.8K Buy | Form 4 ↗ |
| Mar 17, 2026 | Jorey Chernett 10% owner | TOI Starling Oncology, Inc. | Buy | 75,000 | $3.42 | $256.5K Buy | Form 4 ↗ |
| Mar 16, 2026 | Jorey Chernett 10% owner | TOI Starling Oncology, Inc. | Buy | 60,985 | $3.29 | $200.6K Buy | Form 4 ↗ |
| Mar 13, 2026 | Jorey Chernett 10% owner | TOI Starling Oncology, Inc. | Buy | 263,000 | $2.92 | $768.0K Buy | Form 4 ↗ |
| Dec 15, 2025 | Brad Hively Director | TOI Starling Oncology, Inc. | Sale | 13,333 | $3.77 | $50.3K Sale | Form 4 ↗ |
| Nov 18, 2025 | Mark L. Pacala Director | TOI Starling Oncology, Inc. | Sale | 46,630 | $4.00 | $186.5K Sale | Form 4 ↗ |
| Nov 18, 2025 | Mark L. Pacala Director | TOI Starling Oncology, Inc. | Sale | 1,210 | $4.00 | $4,840 Sale | Form 4 ↗ |
| Nov 18, 2025 | Mark L. Pacala Director | TOI Starling Oncology, Inc. | Sale | 2,160 | $4.00 | $8,640 Sale | Form 4 ↗ |
| Sep 4, 2025 | M33 Growth I GP LLC Director, 10% owner | TOI Starling Oncology, Inc. | Sale | 681,832 | $3.09 | $2.1M Sale | Form 4 ↗ |
| Sep 4, 2025 | M33 Growth I GP LLC Director, 10% owner | TOI Starling Oncology, Inc. | Sale | 6.02M | $3.09 | $18.6M Sale | Form 4 ↗ |
| Aug 19, 2025 | Brad Hively Director | TOI Starling Oncology, Inc. | Sale | 20,221 | $4.06 | $82.1K Sale | Form 4 ↗ |
| Jun 5, 2025 | M33 Growth I GP LLC Director, 10% owner | TOI Starling Oncology, Inc. | Sale | 76,324 | $3.05 | $232.8K Sale | Form 4 ↗ |
| Jun 5, 2025 | M33 Growth I GP LLC Director, 10% owner | TOI Starling Oncology, Inc. | Sale | 673,676 | $3.05 | $2.1M Sale | Form 4 ↗ |
| Jun 3, 2025 | Brad Hively Director | TOI Starling Oncology, Inc. | Sale | 108,532 | $2.87 | $311.5K Sale | Form 4 ↗ |
| Jun 3, 2025 | Brad Hively Director | TOI Starling Oncology, Inc. | Sale | 1.87M | $2.87 | $5.4M Sale | Form 4 ↗ |
| May 20, 2025 | M33 Growth I GP LLC Director, 10% owner | TOI Starling Oncology, Inc. | Sale | 203,532 | $2.71 | $551.6K Sale | Form 4 ↗ |
| May 20, 2025 | M33 Growth I GP LLC Director, 10% owner | TOI Starling Oncology, Inc. | Sale | 1.80M | $2.71 | $4.9M Sale | Form 4 ↗ |
| Mar 26, 2025 | Daniel Virnich Chief Executive Officer | TOI Starling Oncology, Inc. | Buy | 22,640 | $1.04 | $23.5K Buy | Form 4 ↗ |
| Mar 26, 2025 | Yale Podnos Chief Medical Officer | TOI Starling Oncology, Inc. | Buy | 9,056 | $1.04 | $9,418 Buy | Form 4 ↗ |
| Mar 26, 2025 | Mark L. Pacala Director | TOI Starling Oncology, Inc. | Buy | 90,562 | $1.04 | $94.2K Buy | Form 4 ↗ |
| Mar 26, 2025 | Karen Marie Johnson Director | TOI Starling Oncology, Inc. | Buy | 36,224 | $1.04 | $37.7K Buy | Form 4 ↗ |
| Mar 26, 2025 | Jeremy Castle Chief Operating Officer | TOI Starling Oncology, Inc. | Buy | 9,056 | $1.04 | $9,418 Buy | Form 4 ↗ |
| Mar 26, 2025 | Robert Ross Carter Chief Financial Officer | TOI Starling Oncology, Inc. | Buy | 9,056 | $1.04 | $9,418 Buy | Form 4 ↗ |
| Mar 26, 2025 | Richard A. Barasch Director | TOI Starling Oncology, Inc. | Buy | 1.36M | $1.04 | $1.4M Buy | Form 4 ↗ |
| Mar 26, 2025 | Brad Hively Director | TOI Starling Oncology, Inc. | Buy | 45,280 | $1.04 | $47.1K Buy | Form 4/A ↗ |
| Dec 2, 2024 | Brad Hively Director | TOI Starling Oncology, Inc. | Buy | 50,000 | $0.15 | $7,500 Buy | Form 4 ↗ |
| Nov 26, 2024 | Brad Hively Director | TOI Starling Oncology, Inc. | Buy | 250,000 | $0.17 | $42.5K Buy | Form 4 ↗ |
47 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:49 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances